Marc S. Ernstoff

Dartmouth Institute for Health Policy and Clinical Practice

Also affiliated with Dartmouth–Hitchcock Medical Center, Dartmouth Psychiatric Research Center, National Cancer Institute, National Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.386Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

PLoS ONE(2023)10.1371/journal.pone.0269324

Top 47%

0.386DataRank

Top 47%10 citations

Keimya Sadeghi, Sharon N. Edmiston, Jessica M. Kenney, Cecilia Lezcano, James S. Wilmott +47 more

Papers

Driven by 22 papers — median percentile 53. Top paper: “Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)”.

Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

Neuro-Oncology(2021)10.1093/neuonc/noab094

N/A

4.0DataRank · unranked

126 citations

Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid +18 more

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

New England Journal of Medicine(2018)10.1056/nejmoa1805453

N/A

1.1DataRank · unranked

1335 citations

Peter A. Forsyth, Alain Algazi, Omid Hamid, F. Stephen Hodi, Stergios J. Moschos +17 more

Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy

Nature Cancer(2021)10.1038/s43018-021-00180-1

N/A

0.754DataRank · unranked

151 citations

Yanding Zhao, Keisuke Shirai, Aleksey Molodtsov, Fred Kolling, Jan L. Fisher +10 more

Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study

Pigment Cell & Melanoma Research(2022)10.1111/pcmr.13058

N/A

0.672DataRank · unranked

21 citations

Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J. Busam, Cecilia Lezcano +40 more

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002553

N/A

0.637DataRank · unranked

69 citations

Poornima Subramanian, Yan Yatsynovich, David M. Jacobs, Maya R. Chilbert, Umesh C. Sharma +17 more

InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma

PLoS ONE(2023)10.1371/journal.pone.0269324

Top 47%

0.386DataRank

Top 47%10 citations

Keimya Sadeghi, Sharon N. Edmiston, Jessica M. Kenney, Cecilia Lezcano, James S. Wilmott +47 more

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance

JCO Precision Oncology(2024)10.1200/po-24-00375

N/A

0.327DataRank · unranked

6 citations

Sharon N. Edmiston, Amanda M. Vondras, Allison Reiner, David L. Corcoran, Ronglai Shen +70 more

A Rapid Exosome Isolation Using Ultrafiltration and Size Exclusion Chromatography (REIUS) Method for Exosome Isolation from Melanoma Cell Lines

Methods in molecular biology(2021)10.1007/978-1-0716-1205-7_22

N/A

0DataRank · unranked

66 citations

Cheryl Allen, Shawna Benjamin-Davalos, Marina Koroleva, Don MacFarland, Hans Minderman +2 more

Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2381

N/A

0DataRank · unranked

145 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Using the tumor microenvironment to identify predictors of immunotoxicity to checkpoint inhibitors.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2545

N/A

0DataRank · unranked

3 citations

Kristopher Attwood, Kayla Catalfamo, Grace K. Dy, Saby George, Marc S. Ernstoff +2 more

Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth

Oncology Reports(2023)10.3892/or.2023.8481

N/A

0DataRank · unranked

2 citations

Xianghua Han, Christine W. Lary, Pradeep Sathyanarayana, Scot C. Remick, Marc S. Ernstoff +3 more

Methylation of nonessential genes in cutaneous melanoma – Rule Out hypothesis

Melanoma Research(2023)10.1097/cmr.0000000000000881

N/A

0DataRank · unranked

0 citations

Kathleen Conway, Sharon N. Edmiston, Eloise Parrish, Honglin Hao, Christopher I. Amos +15 more

Data from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

(2023)10.1158/1078-0432.c.6528354

N/A

0DataRank · unranked

0 citations

Douglas K. Marks, Emanuelle M. Rizk, Margaret H. Bogardus, Camille L. Gérard, Luke W. Barker +15 more

Data from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

(2023)10.1158/1078-0432.c.6530279

N/A

0DataRank · unranked

0 citations

Manu Pandey, Kristopher Attwood, Wenyan Ji, Agnieszka K. Witkiewicz, Erik S. Knudsen +14 more

Immune and Metabolic Reprogramming Induced by Paclitaxel, Capecitabine and Eribulin in Breast Cancer: Insights into Therapeutic Targets

Breast Cancer Targets and Therapy(2025)10.2147/bctt.s498070

N/A

0DataRank · unranked

0 citations

Riya Patel, Paweł Kaliński, Kazuaki Takabe, Marc S. Ernstoff, Spencer R. Rosario +2 more

Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003048

N/A

0DataRank · unranked

10 citations

Rosemarie Aurigemma, Connie L. Sommers, Anju Singh, Kasia Bourcier, Marc S. Ernstoff +1 more

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000331

N/A

0DataRank · unranked

125 citations

Kristina Navrazhina, Fei Ding, Roma Bhatia, Katy K. Tsai, Kelly Abbate +23 more

An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+T Cells is Dependent on IL-10 and Independent of BRAFV600EMutation in Melanoma Cell Lines

Immunological Investigations(2020)10.1080/08820139.2020.1803353

N/A

0DataRank · unranked

19 citations

Junko Matsuzaki, Muzamil Y. Want, Alexis Conway, Shawna Benjamin-Davalos, Cheryl Allen +6 more

Impact of Concomitant Medication Use and Immune-Related Adverse Events on Response to Immune Checkpoint Inhibitors

Immunotherapy(2020)10.2217/imt-2019-0064

N/A

0DataRank · unranked

33 citations

Manu Pandey, Nischala Ammannagari, Chong Wang, Mark J. Bucsek, Lamya Hamad +3 more

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.13.095844

N/A

0DataRank · unranked

3 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors

Nature Communications(2021)10.1038/s41467-021-21619-0

N/A

0DataRank · unranked

188 citations

Toshifumi Hoki, Takaaki Oba, Vaibhav Jain, Hongbin Chen, Kristopher Attwood +11 more

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003277

N/A

0DataRank · unranked

118 citations

David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang +13 more

Marc S. Ernstoff

Indexed papers

Top data-sharing exemplar

Papers